Blume Capital Management, Inc. Neogenomics Inc Transaction History

Blume Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$6.45 - $12.07 $3,225 - $6,035	-500 Reduced 16.39%	2,550 $23,000
Q3 2022 Nov 15, 2022	SELL	$7.86 - $12.91 $4,716 - $7,746	-600 Reduced 16.44%	3,050 $26,000
Q1 2022 May 12, 2022	SELL	$12.15 - $35.28 $2,187 - $6,350	-180 Reduced 4.7%	3,650 $44,000
Q4 2021 Feb 07, 2022	BUY	$30.49 - $48.49 $54,882 - $87,282	1,800 Added 88.67%	3,830 $131,000
Q2 2021 Aug 10, 2021	BUY	$36.62 - $51.69 $74,338 - $104,930	2,030 New	2,030 $92,000

282

124M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.21B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Blume Capital Management, Inc. with notifications on news.